Avita Medical Ltd (RCEL)
Rosen Law Firm Encourages AVITA Medical, Inc. Investors to Inquire About Securities Class Action Investigation – RCEL
Medtronic plc. (MDT)
U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral™ renal denervation (RDN) system
Nektar Therapeutics (NKTR)
Nektar to Announce Financial Results for the Third Quarter on Thursday, November 6, 2025, After Close of U.S.-Based Financial Markets
GENFIT S.A. (GNFT)
GENFIT Announces Advances Across its ACLF Pipeline at AASLD The Liver Meeting® 2025
Rapid Micro Biosystems Inc (RPID)
Rapid Micro Biosystems to Announce Third Quarter 2025 Financial Results on November 7, 2025
Qiagen N.V. (QGEN)
QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample Processing
Tarsus Pharmaceuticals Inc (TARS)
Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
DexCom Inc (DXCM)
DCXM ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc. Investors
Ultragenyx Pharmaceutical Inc (RARE)
Ultragenyx to Host Conference Call for Third Quarter 2025 Financial Results and Corporate Update
Arrowhead Pharmaceuticals Inc (ARWR)
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)